National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Allogeneic hematopoietic cell transplantation Chronic graft-versus-host disease Consensus Gastrointestinal tract Lung Ocular Sclerosis Skin

Journal

Transplantation and cellular therapy
ISSN: 2666-6367
Titre abrégé: Transplant Cell Ther
Pays: United States
ID NLM: 101774629

Informations de publication

Date de publication:
10 2021
Historique:
received: 01 06 2021
accepted: 01 06 2021
pubmed: 5 7 2021
medline: 21 10 2021
entrez: 4 7 2021
Statut: ppublish

Résumé

Chronic graft-versus-host disease (GVHD) can be associated with significant morbidity, in part because of nonreversible fibrosis, which impacts physical functioning (eye, skin, lung manifestations) and mortality (lung, gastrointestinal manifestations). Progress in preventing severe morbidity and mortality associated with chronic GVHD is limited by a complex and incompletely understood disease biology and a lack of prognostic biomarkers. Likewise, treatment advances for highly morbid manifestations remain hindered by the absence of effective organ-specific approaches targeting "irreversible" fibrotic sequelae and difficulties in conducting clinical trials in a heterogeneous disease with small patient numbers. The purpose of this document is to identify current gaps, to outline a roadmap of research goals for highly morbid forms of chronic GVHD including advanced skin sclerosis, fasciitis, lung, ocular and gastrointestinal involvement, and to propose strategies for effective trial design. The working group made the following recommendations: (1) Phenotype chronic GVHD clinically and biologically in future cohorts, to describe the incidence, prognostic factors, mechanisms of organ damage, and clinical evolution of highly morbid conditions including long-term effects in children; (2) Conduct longitudinal multicenter studies with common definitions and research sample collections; (3) Develop new approaches for early identification and treatment of highly morbid forms of chronic GVHD, especially biologically targeted treatments, with a special focus on fibrotic changes; and (4) Establish primary endpoints for clinical trials addressing each highly morbid manifestation in relationship to the time point of intervention (early versus late). Alternative endpoints, such as lack of progression and improvement in physical functioning or quality of life, may be suitable for clinical trials in patients with highly morbid manifestations. Finally, new approaches for objective response assessment and exploration of novel trial designs for small populations are required.

Identifiants

pubmed: 34217703
pii: S2666-6367(21)00949-0
doi: 10.1016/j.jtct.2021.06.001
pmc: PMC8478861
mid: NIHMS1722009
pii:
doi:

Types de publication

Consensus Development Conference, NIH Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

817-835

Subventions

Organisme : NEI NIH HHS
ID : R24 EY032440
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY024966
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL145116
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY021798
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA142106
Pays : United States
Organisme : NEI NIH HHS
ID : R13 EY027189
Pays : United States

Informations de copyright

Copyright © 2021 The American Society for Transplantation and Cellular Therapy. All rights reserved.

Références

Eur Respir J. 2019 May 2;53(5):
pubmed: 30846475
Lancet. 2016 Jun 25;387(10038):2630-2640
pubmed: 27156934
Bone Marrow Transplant. 2018 Jul;53(7):863-872
pubmed: 29382955
Sci Rep. 2017 Feb 06;7:41939
pubmed: 28165054
J Ophthalmic Vis Res. 2013 Oct;8(4):351-8
pubmed: 24653823
Haematologica. 2016 Dec;101(12):1592-1602
pubmed: 27662017
J Clin Invest. 2017 Jun 30;127(7):2452-2463
pubmed: 28665299
Biol Blood Marrow Transplant. 2013 May;19(5):767-76
pubmed: 23376495
Bone Marrow Transplant. 2020 May;55(5):906-917
pubmed: 31740767
Clin Immunol. 2017 Nov;184:54-62
pubmed: 28522286
Am J Clin Pathol. 2016 May;145(5):591-603
pubmed: 27247365
J Comput Assist Tomogr. 2012 Jul-Aug;36(4):431-6
pubmed: 22805673
Blood. 2019 Jul 18;134(3):304-316
pubmed: 31043425
Biol Blood Marrow Transplant. 2016 Oct;22(10):1765-1772
pubmed: 27492793
Biol Blood Marrow Transplant. 2016 Apr;22(4):710-716
pubmed: 26475726
Haematologica. 2012 Mar;97(3):451-8
pubmed: 22058206
Mol Vis. 2012;18:797-802
pubmed: 22509110
Lab Invest. 2007 May;87(5):417-29
pubmed: 17334409
Curr Opin Allergy Clin Immunol. 2012 Oct;12(5):540-7
pubmed: 22892710
JCI Insight. 2016 Aug 4;1(12):e87001
pubmed: 27699226
Biol Blood Marrow Transplant. 2018 Sep;24(9):1906-1913
pubmed: 29679771
Biol Blood Marrow Transplant. 2018 Jun;24(6):1237-1242
pubmed: 29378303
Sci Immunol. 2019 Dec 6;4(42):
pubmed: 31811055
Ocul Surf. 2019 Jul;17(3):589-614
pubmed: 30965123
Biol Blood Marrow Transplant. 2016 Apr;22(4):744-751
pubmed: 26762681
Cell Res. 2020 Jun;30(6):492-506
pubmed: 32433595
Bone Marrow Transplant. 2015 Aug;50(8):1098-104
pubmed: 25961774
Biol Blood Marrow Transplant. 2013 Jun;19(6):973-80
pubmed: 23562737
Histopathology. 2018 Nov;73(5):832-842
pubmed: 29953629
Br J Ophthalmol. 1999 Oct;83(10):1125-30
pubmed: 10502571
Arthritis Rheum. 2010 Feb;62(2):580-8
pubmed: 20112379
Bone Marrow Transplant. 2018 Nov;53(11):1401-1415
pubmed: 29872128
Blood. 2002 Apr 15;99(8):2940-7
pubmed: 11929785
PLoS One. 2012;7(9):e44922
pubmed: 23028681
Blood. 2013 Mar 7;121(10):1906-10
pubmed: 23299314
Biol Blood Marrow Transplant. 2016 Mar;22(3):449-55
pubmed: 26541363
Biol Blood Marrow Transplant. 2015 Jul;21(7):1308-14
pubmed: 25840337
Chest. 2020 Sep;158(3):1090-1103
pubmed: 32343962
Biol Blood Marrow Transplant. 2003 Oct;9(10):657-66
pubmed: 14569562
Front Immunol. 2019 Jan 17;9:3179
pubmed: 30705680
Nature. 2015 Dec 24;528(7583):560-564
pubmed: 26649819
Blood. 2017 May 4;129(18):2570-2580
pubmed: 28254742
Br J Clin Pharmacol. 2018 Oct;84(10):2280-2291
pubmed: 29900565
Hum Gene Ther. 2011 Sep;22(9):1035-8
pubmed: 21932992
Eur Respir J. 2016 Dec;48(6):1807-1810
pubmed: 27587560
Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):146-149
pubmed: 30277862
J Cancer Res Clin Oncol. 2013 Aug;139(8):1397-404
pubmed: 23728535
Cell Biol Int. 2017 Sep;41(9):960-968
pubmed: 28493530
Biol Blood Marrow Transplant. 2005 Dec;11(12):945-56
pubmed: 16338616
J Heart Lung Transplant. 2011 Jul;30(7):735-42
pubmed: 21419659
Mod Pathol. 2010 May;23(5):720-8
pubmed: 20190732
Transplant Cell Ther. 2021 Jul;27(7):545-557
pubmed: 33839317
J Eur Acad Dermatol Venereol. 2003 Jul;17(4):402-7
pubmed: 12834449
J Clin Invest. 2015 Jul 1;125(7):2795-807
pubmed: 26098215
Ocul Surf. 2017 Oct;15(4):784-788
pubmed: 28789979
Blood. 2014 Mar 20;123(12):1967-9
pubmed: 24652969
Blood. 2003 Nov 15;102(10):3822-8
pubmed: 12869516
Blood. 2010 Aug 5;116(5):819-28
pubmed: 20435882
Front Psychol. 2017 Mar 10;8:253
pubmed: 28344563
Lasers Surg Med. 2018 Mar;50(3):183-193
pubmed: 29356051
Connect Tissue Res. 2019 Jan;60(1):40-49
pubmed: 30056769
Cornea. 2018 Jan;37(1):102-108
pubmed: 29053559
Blood. 2018 Mar 29;131(13):1476-1485
pubmed: 29363541
Arthritis Rheum. 2011 May;63(5):1396-404
pubmed: 21312186
Biol Blood Marrow Transplant. 2013 May;19(5):784-91
pubmed: 23395601
Blood. 2020 Jul 2;136(1):130-136
pubmed: 32430495
Nature. 2019 Sep;573(7774):430-433
pubmed: 31511695
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13827-13832
pubmed: 27834728
Lancet Respir Med. 2021 Jun;9(6):601-612
pubmed: 33460570
Bone Marrow Transplant. 2015 Jul;50(7):961-7
pubmed: 25893453
Am J Transplant. 2020 Aug;20(8):2198-2205
pubmed: 32034974
Bone Marrow Transplant. 2015 Nov;50(11):1459-64
pubmed: 26301966
Blood Rev. 2020 Nov;44:100674
pubmed: 32199685
Bone Marrow Transplant. 2015 Sep;50(9):1227-34
pubmed: 26052909
Blood. 2021 Feb 18;137(7):896-907
pubmed: 32976576
Pediatr Pulmonol. 2008 Oct;43(10):1020-4
pubmed: 18785259
Blood. 2012 Oct 25;120(17):3407-18
pubmed: 22898605
Blood Adv. 2019 Apr 9;3(7):1003-1010
pubmed: 30940635
ERJ Open Res. 2019 Oct 30;5(4):
pubmed: 31687370
Acad Radiol. 2018 Sep;25(9):1201-1212
pubmed: 29472146
Eur Respir J. 2018 May 3;51(5):
pubmed: 29650555
Am J Respir Crit Care Med. 2018 Apr 15;197(8):1045-1057
pubmed: 29236513
Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8253-63
pubmed: 23169882
Ophthalmology. 2015 Aug;122(8):1669-74
pubmed: 26001816
Lancet Respir Med. 2020 Jan;8(1):25-33
pubmed: 31575509
Arthritis Rheumatol. 2020 Aug;72(8):1350-1360
pubmed: 32336038
Arthritis Rheumatol. 2016 Feb;68(2):299-311
pubmed: 26808827
Dtsch Med Wochenschr. 2009 May;134(21):1106-9
pubmed: 19437374
Am J Respir Crit Care Med. 2014 Jan 15;189(2):159-66
pubmed: 24325429
J Immunol. 2016 Nov 1;197(9):3490-3503
pubmed: 27694491
Nippon Ganka Gakkai Zasshi. 2016 Nov;120(11):743-5
pubmed: 30074738
Am J Respir Crit Care Med. 2015 Jun 1;191(11):1242-9
pubmed: 25835160
Cornea. 2018 Apr;37(4):486-494
pubmed: 29341972
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4519-27
pubmed: 16303943
Biol Blood Marrow Transplant. 2020 May;26(5):943-948
pubmed: 31821885
Blood. 2011 Oct 13;118(15):4070-8
pubmed: 21828142
Blood. 2012 Jul 5;120(1):223-31
pubmed: 22535662
Blood Adv. 2017 Oct 05;1(22):1919-1922
pubmed: 29296838
Blood. 2016 Jul 7;128(1):130-7
pubmed: 27073224
JAMA. 2002 Nov 6;288(17):2118; author reply 2119
pubmed: 12413365
Blood. 2012 Feb 9;119(6):1570-80
pubmed: 22072556
Blood. 2014 Jun 19;123(25):3988-98
pubmed: 24820310
Biol Blood Marrow Transplant. 2003 Jan;9(1):46-51
pubmed: 12533741
Blood. 2007 Jul 1;110(1):237-41
pubmed: 17363728
J Invest Dermatol. 2021 Apr;141(4):924-927.e2
pubmed: 32950506
Bone Marrow Transplant. 2015 Feb;50(2):253-8
pubmed: 25365068
Blood. 2011 Dec 15;118(25):6702-8
pubmed: 21979939
Blood. 2021 Mar 4;137(9):1241-1255
pubmed: 33027805
Ocul Surf. 2019 Jan;17(1):160-166
pubmed: 30399438
Arthritis Res Ther. 2017 Jun 13;19(1):134
pubmed: 28610597
Bone Marrow Transplant. 2013 Jun;48(6):819-24
pubmed: 23208317
Blood. 2021 Apr 29;137(17):2403-2416
pubmed: 33529322
Ann Am Thorac Soc. 2016 Nov;13(11):1932-1939
pubmed: 27513368
Sci Adv. 2019 Oct 09;5(10):eaax5851
pubmed: 31633026
J Immunol. 1999 Nov 15;163(10):5693-9
pubmed: 10553100
Invest Ophthalmol Vis Sci. 2013 Dec 11;54(13):8051-61
pubmed: 24255046
Blood. 2016 Feb 4;127(5):646-57
pubmed: 26670634
Cornea. 2017 Feb;36(2):258-263
pubmed: 28060078
Arthritis Rheumatol. 2021 Jul;73(7):1301-1310
pubmed: 33538094
Clin Ophthalmol. 2013;7:2153-8
pubmed: 24204119
Virchows Arch. 2015 Sep;467(3):255-63
pubmed: 26164839
Ann Rheum Dis. 2012 Jul;71(7):1235-42
pubmed: 22586157
Ocul Surf. 2016 Jul;14(3):393-400
pubmed: 27179980
Biochem Pharmacol. 2018 Nov;157:304-313
pubmed: 30076848
FASEB J. 2020 Aug;34(8):10778-10800
pubmed: 32619061
Semin Hematol. 2012 Jan;49(1):43-58
pubmed: 22221784
J Dermatol Sci. 2020 Jan;97(1):41-49
pubmed: 31836271
J Heart Lung Transplant. 2019 May;38(5):483-492
pubmed: 31027539
Stroke. 2004 May;35(5):1158-63
pubmed: 15073401
Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603
pubmed: 25639770
Hum Pathol. 1986 Jun;17(6):621-33
pubmed: 3011641
Biol Blood Marrow Transplant. 2014 Sep;20(9):1341-8
pubmed: 24813171
Methods Mol Biol. 2018;1799:49-57
pubmed: 29956143
Bone Marrow Transplant. 2020 Sep;55(9):1851-1853
pubmed: 32042103
Immunity. 2012 Aug 24;37(2):339-50
pubmed: 22921121
Am J Transplant. 2007 Jan;7(1):76-82
pubmed: 17061983
Biol Blood Marrow Transplant. 2020 Feb;26(2):392-400
pubmed: 31682980
JAMA. 2017 Aug 8;318(6):557-566
pubmed: 28787506
Blood. 2017 Jun 8;129(23):3121-3125
pubmed: 28416503
Haematologica. 2014 Oct;99(10):1618-23
pubmed: 24997150
Biol Blood Marrow Transplant. 2011 Jul;17(7):1072-8
pubmed: 21126596
Blood. 2013 Jul 18;122(3):463-5
pubmed: 23869081
Biol Blood Marrow Transplant. 2017 Feb;23(2):211-234
pubmed: 27713092
N Engl J Med. 2020 Jan 16;382(3):211-221
pubmed: 31851795
Biol Blood Marrow Transplant. 2017 Jan;23(1):140-146
pubmed: 27751934
Bone Marrow Transplant. 2019 Apr;54(4):616-619
pubmed: 30287938
Klin Monbl Augenheilkd. 2017 Apr;234(4):455-456
pubmed: 28329888
Am J Pathol. 2009 Dec;175(6):2372-81
pubmed: 19893038
Biol Blood Marrow Transplant. 2016 Oct;22(10):1781-1791
pubmed: 27343720
Blood. 2013 Mar 7;121(10):1886-95
pubmed: 23303823
Clin Cancer Res. 2016 Jan 15;22(2):319-27
pubmed: 26378033
Bone Marrow Transplant. 2020 May;55(5):982-986
pubmed: 31413312
Pharmacol Ther. 2020 Apr;208:107477
pubmed: 31926199
Nat Rev Rheumatol. 2019 Dec;15(12):705-730
pubmed: 31712723
Cornea. 2015 Mar;34(3):243-7
pubmed: 25603230
Biol Blood Marrow Transplant. 2015 Sep;21(9):1687-91
pubmed: 26033283
Biol Blood Marrow Transplant. 2015 Jun;21(6):984-99
pubmed: 25796139
Eye (Lond). 2007 Dec;21(12):1493-500
pubmed: 17057649
Blood. 2016 Sep 15;128(11):1516-24
pubmed: 27313329
Front Immunol. 2018 Oct 16;9:2328
pubmed: 30459752
PLoS One. 2013 Jun 06;8(6):e64724
pubmed: 23762250
Immunity. 2019 Jul 16;51(1):90-103.e3
pubmed: 31278057
J Exp Med. 2017 Dec 4;214(12):3507-3518
pubmed: 29066578
JCI Insight. 2017 Apr 20;2(8):
pubmed: 28422760
Hum Pathol. 2018 Feb;72:174-179
pubmed: 28899741
Bone Marrow Transplant. 2015 Jan;50(1):3-9
pubmed: 25347009
Biol Blood Marrow Transplant. 2018 Apr;24(4):734-740
pubmed: 29246821
Front Immunol. 2020 Aug 25;11:2017
pubmed: 32983144
Exp Eye Res. 2017 Jan;154:64-69
pubmed: 27818317
Am J Ophthalmol. 2018 May;189:102-110
pubmed: 29505774
Ann Rheum Dis. 2018 Sep;77(9):1362-1371
pubmed: 29853453
Blood Adv. 2019 Oct 8;3(19):2866-2869
pubmed: 31585950
Blood. 2020 Apr 9;135(15):1287-1298
pubmed: 32047896
Biol Blood Marrow Transplant. 2014 Nov;20(11):1751-7
pubmed: 25042736
Arthritis Rheumatol. 2015 Nov;67(11):3004-15
pubmed: 26240058
Bone Marrow Transplant. 2010 Jun;45(6):1077-83
pubmed: 19898506
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
Blood. 2012 Oct 4;120(14):2909-17
pubmed: 22915638
Clin Nucl Med. 2013 Aug;38(8):e309-17
pubmed: 23455525
Blood. 2013 Jun 20;121(25):5098-103
pubmed: 23547053
Transplant Cell Ther. 2021 Jun;27(6):448-451
pubmed: 33785366
Blood. 2005 Sep 15;106(6):2206-14
pubmed: 15941908
Arthritis Rheum. 2010 Nov;62(11):3467-76
pubmed: 20617520
Int Ophthalmol Clin. 2017 Spring;57(2):65-88
pubmed: 28282315
Bone Marrow Transplant. 2018 Apr;53(4):490-494
pubmed: 29330389
Ann Hematol. 2016 Feb;95(3):493-9
pubmed: 26659079
Ocul Surf. 2020 Apr;18(2):298-304
pubmed: 31954196
Blood. 2014 Jan 9;123(2):290-9
pubmed: 24255916
Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2348-57
pubmed: 25655798
Surv Ophthalmol. 2013 May-Jun;58(3):233-51
pubmed: 23541042
Med Sci Monit. 2011 Jun;17(6):CR322-8
pubmed: 21629186
Bone Marrow Transplant. 2013 Sep;48(9):1249-52
pubmed: 23749110
J Exp Med. 2011 Feb 14;208(2):285-94
pubmed: 21282378
Br J Ophthalmol. 1993 Aug;77(8):525-6
pubmed: 8025052
Cell. 2020 May 14;181(4):848-864.e18
pubmed: 32298651
Oncol Res Treat. 2015;38(10):532-4
pubmed: 26452109
Ann Hematol. 2020 Apr;99(4):847-853
pubmed: 32086584
Ann Rheum Dis. 2011 Jul;70(7):1304-10
pubmed: 21450749
Cancer. 2019 Jan 1;125(1):144-152
pubmed: 30368771
Mol Vis. 2011;17:2533-43
pubmed: 22025888
Sci Adv. 2018 Jul 11;4(7):eaas9944
pubmed: 30009261
Arthritis Rheumatol. 2016 Dec;68(12):2964-2974
pubmed: 27390295
Ocul Surf. 2020 Jan;18(1):98-107
pubmed: 31605785
Front Immunol. 2019 Jan 24;9:3104
pubmed: 30733722
J Invest Dermatol. 2017 Dec;137(12):2473-2483
pubmed: 28807667
Hematol Oncol. 2018 Feb;36(1):291-298
pubmed: 28547857
Blood. 2016 Apr 28;127(17):2144-54
pubmed: 26983850
Arch Dermatol. 2009 Aug;145(8):918-22
pubmed: 19687424
J Clin Invest. 2013 Sep;123(9):3967-82
pubmed: 23945235
Bone Marrow Transplant. 2009 Jan;43(2):159-67
pubmed: 18762758
Am J Respir Crit Care Med. 2015 Jul 15;192(2):209-18
pubmed: 25922973
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1
pubmed: 25529383
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1079-86
pubmed: 17325149
Biol Blood Marrow Transplant. 2011 Dec;17(12):1862-8
pubmed: 21745454
AJR Am J Roentgenol. 2009 May;192(5):1401-6
pubmed: 19380569
Invest Ophthalmol Vis Sci. 2001 Jan;42(1):111-9
pubmed: 11133855
FASEB J. 2018 Aug;32(8):4085-4095
pubmed: 29490166
JCI Insight. 2018 Oct 4;3(19):
pubmed: 30282825
Blood. 2007 Nov 1;110(9):3463-71
pubmed: 17664354
N Engl J Med. 2011 Dec 1;365(22):2055-66
pubmed: 22129252
Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2692-7
pubmed: 16043840
Ann Rheum Dis. 2014 Jun;73(6):1264-8
pubmed: 24445254
Nat Rev Clin Oncol. 2011 Nov 08;9(4):199-207
pubmed: 22064459
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4511-4519
pubmed: 31675422
Ophthalmology. 1999 Jul;106(7):1334-8
pubmed: 10406617
Biol Blood Marrow Transplant. 2012 Aug;18(8):1250-4
pubmed: 22300617
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Bone Marrow Transplant. 2014 Jun;49(6):854-6
pubmed: 24637899
Blood. 2011 Oct 13;118(15):4250-7
pubmed: 21791415
Respir Med Case Rep. 2020 Jul 09;31:101161
pubmed: 32695572
Psychooncology. 2013 Jul;22(7):1509-16
pubmed: 22945857
Bone Marrow Transplant. 2016 Nov;51(11):1513-1517
pubmed: 27272447
Transplantation. 2012 May 15;93(9):949-57
pubmed: 22377792
Blood. 2017 Dec 28;130(26):2889-2899
pubmed: 29138220
BMJ. 1995 Dec 16;311(7020):1621-5
pubmed: 8555809
Elife. 2016 Jan 26;5:e09394
pubmed: 26809474
Biol Blood Marrow Transplant. 2019 Apr;25(4):800-809
pubmed: 30521974
Ultrasound Med Biol. 2020 May;46(5):1263-1269
pubmed: 32111457
Blood Adv. 2019 Sep 24;3(18):2764-2777
pubmed: 31551243
J Infect Dis. 2006 Jun 15;193(12):1619-25
pubmed: 16703503
Ultrasound Med Biol. 2015 Nov;41(11):2806-19
pubmed: 26259888
Mol Oncol. 2015 May;9(5):951-9
pubmed: 25888066
Blood Adv. 2020 Mar 24;4(6):983-992
pubmed: 32168378
Sci Rep. 2013 Dec 05;3:3419
pubmed: 24305504
Expert Opin Drug Deliv. 2019 Aug;16(8):847-867
pubmed: 31311345
Brain. 2010 Oct;133(10):2852-65
pubmed: 20846944
J Clin Invest. 2014 Oct;124(10):4266-80
pubmed: 25157821
Lancet. 2002 Jun 15;359(9323):2078-83
pubmed: 12086762
J Clin Invest. 2020 Mar 2;130(3):1315-1329
pubmed: 31846439
Skin Res Technol. 2013 Feb;19(1):e417-22
pubmed: 22882597
Biol Blood Marrow Transplant. 2014 Jul;20(7):1008-13
pubmed: 24704386
Bone Marrow Transplant. 2013 Nov;48(11):1429-36
pubmed: 23665819

Auteurs

Daniel Wolff (D)

Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. Electronic address: daniel.wolff@ukr.de.

Vedran Radojcic (V)

Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Robert Lafyatis (R)

Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Resat Cinar (R)

Section on Fibrotic Disorders, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.

Rachel K Rosenstein (RK)

Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.

Edward W Cowen (EW)

Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland.

Guang-Shing Cheng (GS)

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

Ajay Sheshadri (A)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Anne Bergeron (A)

Department of Pulmonary Medicine, AP-HP Saint Louis Hospital & University of Paris, Paris, France.

Kirsten M Williams (KM)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.

Jamie L Todd (JL)

Division of Pulmonary, Allergy and Critical Care Medicine, Duke University, Durham, North Carolina.

Takanori Teshima (T)

Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.

Geoffrey D E Cuvelier (GDE)

Pediatric Blood and Marrow Transplant, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.

Ernst Holler (E)

Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Shannon R McCurdy (SR)

Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.

Robert R Jenq (RR)

Departments of Genomic Medicine and Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

Alan M Hanash (AM)

Departments of Medicine and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

David Jacobsohn (D)

Children's National Hospital, George Washington University, Washington, District of Columbia.

Bianca D Santomasso (BD)

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York New York.

Sandeep Jain (S)

Department of Ophthalmology, University of Illinois Eye & Ear Infirmary, Chicago, Illinois.

Yoko Ogawa (Y)

Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.

Philipp Steven (P)

Division for Dry-Eye and ocular GvHD, Department of Ophthalmology, Medical Faculty and University Hospital, University of Cologne, Cologne, Germany.

Zhonghui Katie Luo (ZK)

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.

Tina Dietrich-Ntoukas (T)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin und Humboldt-Universität Berlin, Department of Ophthalmology, Berlin, Germany.

Daniel Saban (D)

Department of Ophthalmology and Department of Immunology, Duke University School of Medicine, Durham, North Carolina.

Ervina Bilic (E)

Department of Neurology, University of Zagreb School of Medicine, Zagreb, Croatia.

Olaf Penack (O)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany.

Linda M Griffith (LM)

Division of Allergy Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

Meredith Cowden (M)

Cowden Foundation, Akron, Ohio.

Paul J Martin (PJ)

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

Hildegard T Greinix (HT)

Clinical Division of Hematology, Medical University of Graz, Graz, Austria.

Stefanie Sarantopoulos (S)

Division of Hematological Malignancies and Cellular Therapy, Duke University Department of Medicine, Duke Cancer Institute, Durham, North Carolina.

Gerard Socie (G)

Hematology Transplantation, AP-HP Saint Louis Hospital & University of Paris, Paris, France.

Bruce R Blazar (BR)

Department of Pediatrics, Division of Blood & Marrow Transplant & Cellular Therapy, University of Minnesota, Minneapolis, Minnesota.

Joseph Pidala (J)

Department of Blood and Marrow Transplantation and Cellular Immunotherapy. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

Carrie L Kitko (CL)

Pediatric Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee.

Daniel R Couriel (DR)

Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Corey Cutler (C)

Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.

Kirk R Schultz (KR)

Pediatric Hematology/Oncology/BMT, BC Children's Hospital, Vancouver, British Columbia, Canada.

Steven Z Pavletic (SZ)

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Stephanie J Lee (SJ)

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

Sophie Paczesny (S)

Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH